Ingevity Corp (NGVT) - Total Liabilities

Latest as of June 2026: $1.49 Billion USD

Based on the latest financial reports, Ingevity Corp (NGVT) has total liabilities worth $1.49 Billion USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore how much of Ingevity Corp's assets are long-term investments to see how much of total assets are deployed in long-term investments.

Ingevity Corp - Total Liabilities Trend (2013–2025)

This chart illustrates how Ingevity Corp's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see NGVT asset base.

Ingevity Corp Competitors by Total Liabilities

The table below lists competitors of Ingevity Corp ranked by their total liabilities.

Company Country Total Liabilities
Hufvudstaden AB (publ)
ST:HUFV-A
Sweden Skr21.47 Billion
Zhejiang Yongtai Technology Co Ltd
SHE:002326
China CN¥8.21 Billion
Electra Ltd
TA:ELTR
Israel ILA10.12 Billion
Guangdong Topstar Technology Co Ltd
SHE:300607
China CN¥3.10 Billion
Energisa S.A
SA:ENGI3
Brazil R$63.14 Billion
Zhongshan Public Utilities Group Co Ltd
SHE:000685
China CN¥17.48 Billion
China Science Publishing & Media Ltd
SHG:601858
China CN¥1.68 Billion
Fabege AB
ST:FABG
Sweden Skr45.61 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Ingevity Corp's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See net asset quality index of Ingevity Corp to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.61 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 31.78 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.97 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ingevity Corp's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ingevity Corp (2013–2025)

The table below shows the annual total liabilities of Ingevity Corp from 2013 to 2025.

Year Total Liabilities Change
2025-12-31 $1.62 Billion -11.27%
2024-12-31 $1.83 Billion -8.26%
2023-12-31 $1.99 Billion -2.27%
2022-12-31 $2.04 Billion +13.54%
2021-12-31 $1.80 Billion +6.40%
2020-12-31 $1.69 Billion +4.56%
2019-12-31 $1.61 Billion +65.40%
2018-12-31 $975.60 Million +49.49%
2017-12-31 $652.60 Million -6.53%
2016-12-31 $698.20 Million +168.54%
2015-12-31 $260.00 Million -12.75%
2014-12-31 $298.00 Million +12.45%
2013-12-31 $265.00 Million --

About Ingevity Corp

NYSE:NGVT USA Specialty Chemicals
Market Cap
$2.34 Billion
Market Cap Rank
#5657 Global
#1848 in USA
Share Price
$68.20
Change (1 day)
+0.21%
52-Week Range
$46.20 - $77.87
All Time High
$117.07
About

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies. The Performance Materials segment engineers, manufactures, and sell… Read more